AzTrials
AzTrials

Hearing LossSPHEARNCT05468567

Three-dimensional Perception of Sounds in Military with Acoustic Trauma

An observational study of Hearing Loss, run by Hospices Civils de Lyon at 1 site in France.

Unknown status

Status not confirmed. The sponsor has not verified this record for over two years, so it may be out of date.

Official record
Search all trials

Trial summary

Spatial hearing capacities of soldiers with acoustic trauma are evaluated in ENT consultations with routine tests (i.e. tonal audiometry, voice audiometry). While the results conclude that soldiers with acoustic trauma have sufficient abilities to carry out professional missions, soldiers report recurring complaints… Read more about this study

Who is it for?
Ages 18 to 65 yearsHealthy volunteers can take part
Conditions the study is for
Hearing Loss
What is being tested?
SPHERE protocol : Spatial hearing performances test, French Matrix Test : audiology test of speech in noise perception and SSQ15 questionnaire of life : (The Speech, Spatial and Other Qualities of Hearing Scale)
How many people
46 participants
Where
1 siteFrance
Study dates
31 Mar 2023to 31 Mar 2026
Phase
Observational
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 65 years
  • All sexes
  • Healthy volunteers accepted
  • Adult, Older adult

Study population: The Army Training Hospital of Lyon or within the medical branches of the Army Medical Centers are the structures where the soldiers will recruited. The Neurosciences research Center of Lyon or the ENT department of Edouard Herriot Hospital will recruit the normal hearing volunteers.

Who may be able to join

  • acoustic traumatized military group :
  • Age between 18 and 65 inclusive
  • Active or reserve military personnel
  • Diagnosis of noise trauma for at least one month
  • Regularly followed up in the ENT department of the Desgenettes Army Training Hospital in Lyon or in the medical offices of the Army Medical Centers.
  • Able to understand the experimental instructions
Show all 12Show fewer
  • Affiliated to a social security scheme
  • Having been informed of the study and having given their agreement to participate normal hearing group :
  • Age between 18 and 65 years inclusive
  • Able to understand the experimental instructions
  • Affiliated to a social security scheme
  • Having been informed of the study and given their agreement to participate

Who cannot join

  • Known current or past neurological or psychiatric disorder
  • Oculomotor/visual disorder
  • Bilateral vestibular areflexia
  • Person under court protection, guardianship or curatorship
  • Pregnant or breastfeeding woman
  • Known hearing loss for normal hearing group

Trial locations and contacts

1 site in 1 country.

France1 site, 1 recruiting
  • Hopital Edouard Herriot

    Lyon, 69003

    ERIC TRUY, MD, + 33 4 72 11 05 18, eric.truy@chu-lyon.fr

    ERIC TRUY, MD

    Recruiting

Other trials in France

About this study

Spatial hearing capacities of soldiers with acoustic trauma are evaluated in ENT consultations with routine tests (i.e. tonal audiometry, voice audiometry). While the results conclude that soldiers with acoustic trauma have sufficient abilities to carry out professional missions, soldiers report recurring complaints of sound localization (spatial hearing), i.e. difficulties in identifying the position of sound sources in their environment. However, there is currently no objective test to identify and objectify these complaints of spatial hearing.

The investigators have developed a new approach (SPHERE) based on virtual reality and 3D motion tracking, allowing us to evaluate and record the spatial hearing performance of subject with hearing deficit. This system allowed us to highlight localization deficits in three-dimensional space.

This project explores and quantifies the spatial hearing impairments of soldiers with acoustic trauma. The quantification of the spatial hearing capacities will allow to define a specific rehabilitation strategy of spatial hearing deficits.

Conditions
Hearing Loss
Being tested
SPHERE protocol : Spatial hearing performances test, French Matrix Test : audiology test of speech in noise perception, SSQ15 questionnaire of life : (The Speech, Spatial and Other Qualities of Hearing Scale)
Keywords
Spatial hearing, virtual reality, acoustic trauma, hearing loss
Medical subject headings
Hearing Loss, Hearing Loss, Noise-Induced

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • SPHERE protocol : Spatial hearing performances testDiagnostic test

    Participants will be instructed to localize a sound emitted in their environment using a virtual reality setup (SPHEAR protocol).

  • French Matrix Test : audiology test of speech in noise perceptionDiagnostic test

    Intelligibility threshold is the signal-to-noise ratio (in decibels) for which the subject can repeat 50% of the words heard in a dichotic listening.

  • SSQ15 questionnaire of life : (The Speech, Spatial and Other Qualities of Hearing Scale)Behavioural

    The SSQ questionnaire is a clinical subjective scale that allows evaluating of hearing performances in daily life. The questionnaire is divided into 3 main items (A: speech; B: spatial hearing; C: other qualities of hearing) comprising questions with rating scores out of ten.

Study groups in NCT05468567
Study groupRoleWhat they receive
Military person with acoustic trauma (experimental group)Active or reserve military member, diagnosed with acoustic trauma for at least one month. Participants will be instructed to localize a sound emitted in their environment using a virtual reality setup.
Receives: Diagnostic Test: SPHERE protocol : Spatial hearing performances test; Diagnostic Test: French Matrix Test : audiology test of speech in noise perception; Behavioral: SSQ15 questionnaire of life : (The Speech, Spatial and Other Qualities of Hearing Scale)
Normal hearing volunteers (control group)Person without known hearing loss.
Receives: Diagnostic Test: SPHERE protocol : Spatial hearing performances test; Diagnostic Test: French Matrix Test : audiology test of speech in noise perception; Behavioral: SSQ15 questionnaire of life : (The Speech, Spatial and Other Qualities of Hearing Scale)

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Cumulative error value "3d-D" measuring the spatial hearing performances

    First, the pointing error will be computed for azimuth, elevation, and depth, in terms of constant error and variable error. Then, these separate dimension errors will be combined into a cumulative error "3d-D", taking into account absolute and variable error in one measure. 3d-D value corresponding to the spatial hearing deficit matching the distance between the 3D hand pointing position and the 3D sound source position.

    The 3dD performance of the Acoustic traumatised military group will be compared to that of the normal hearing group.

    Measured: at Day 1 during the inclusion visit. The test last 30 minutes.

Secondary outcomes (2)
  1. Correlation between the score obtained in the SSQ and the 3dD auditory spatialization performance.

    The behavioral (dependent) variables from the SSQ of the acoustic traumatized military will be analyzed using the linear regression method to examine the relationship between their 3dD auditory spatialization performance and their SSQ score

    Measured: at Day 1 during the inclusion visit.

  2. Correlation between the score obtained in the Framatrix and the 3dD auditory spatialization performance.

    The speech-in-noise performance (SNR) of the acoustic traumatized military will be analysed using the linear regression method to examine the relationship between their speech-in-noise performance (SNR) and their SSQ score

    Measured: at Day 1 during the inclusion visit.

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted21 Jul 2022
  2. Study start31 Mar 2023
  3. Primary completion31 Mar 2026 (estimated)
  4. Study completion31 Mar 2026 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Case-control
Time perspective
Prospective
Enrolment
46 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT05468567
Sponsor's protocol ID
69HCL21_0692
Acronym
SPHEAR
Status last verified
Sep 2024
First submitted
1 Jul 2022
Last updated
25 Sep 2024
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No

Questions about this trial

What is this clinical trial studying?

An observational study of Hearing Loss, run by Hospices Civils de Lyon at 1 site in France.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 12 inclusion and 6 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: status not confirmed, as of the sponsor's last update on 25 Sep 2024. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in France. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

Results are not available in the source record.

How can a doctor refer a patient or contact the research team?

Contact Eric Truy, Pr (+33 4 72 11 04 92, eric.truy@chu-lyon.fr), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Cumulative error value "3d-D" measuring the spatial hearing performances (time frame: at Day 1 during the inclusion visit. The test last 30 minutes.). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 25 Sep 2024.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in